老年肾移植受者中的痴呆与阿尔茨海默病
研究纳入1999年1月1日至2011年12月31日美国40,918例年龄≥55岁的肾移植受者,估算移植后痴呆与阿尔茨海默病风险。10年痴呆风险从55-60岁组的5.1%升至≥75岁组的17.0%,阿尔茨海默病风险从1.0%升至6.7%;发生痴呆者移植物丢失与死亡风险显著升高。
要点
- 年龄≥55岁肾移植受者10年痴呆风险5.1%-17.0%,随年龄递增。
- 10年阿尔茨海默病风险1.0%-6.7%,最强预测因素为受者年龄和移植前糖尿病。
- 发生痴呆者移植物丢失风险HR 1.52、死亡风险HR 2.38,阿尔茨海默病结果类似。
核心结论
- 老年肾移植受者移植后痴呆与阿尔茨海默病风险高,且这些后遗症对患者和移植物生存有深远影响。
研究设计与样本
- 研究为队列研究,纳入1999年1月1日至2011年12月31日美国肾脏数据系统中40,918例年龄≥55岁的肾移植受者,并与Medicare索赔数据链接。
- 采用竞争风险模型研究痴呆和阿尔茨海默病相关因素,采用校正Cox比例风险模型分别估算痴呆或阿尔茨海默病亚型后的移植物丢失和死亡风险。
主要发现
- 10年痴呆风险:55-60岁组为5.1%,≥75岁组为17.0%;10年阿尔茨海默病风险:55-60岁组为1.0%,≥75岁组为6.7%。
- 痴呆和阿尔茨海默病最强预测因素为受者年龄较大和移植前糖尿病。
- 10年移植物丢失风险:未发生痴呆组为28.8%,发生痴呆组为43.1%;相应死亡风险分别为55.7%和89.9%。
- 发生痴呆的老年受者移植物丢失风险增加1.52倍(95%CI 1.39-1.68),死亡风险增加2.38倍(95%CI 2.26-2.49)。
- 阿尔茨海默病结果与痴呆结果相似。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Older patients with ESRD who receive a kidney transplant (KT) may develop post-KT dementia and Alzheimer's disease (AD) associated with their long-standing kidney disease and/or neurotoxic immunosuppressant agents. To investigate this possibility, we studied 40,918 older (aged ≥55 years) KT recipients (January 1, 1999 to December 31, 2011) linked to Medicare claims through the US Renal Data System. We estimated dementia and AD risk (cumulative incidence) and studied factors associated with these sequelae using competing risks models. We estimated the risk of death-censored graft loss and mortality after developing dementia or the AD subtype of dementia, separately, using adjusted Cox proportional hazards models. Older recipients had a 10-year dementia risk ranging from 5.1% for recipients aged 55-60 years to 17.0% for recipients aged ≥75 years; 10-year AD risk ranged from 1.0% to 6.7%, respectively. The strongest predictors for dementia and AD were older recipient age and pretransplant diabetes. The 10-year graft loss risk was 28.8% for those who did not develop dementia and 43.1% for those who did, and the corresponding mortality risks were 55.7% and 89.9%, respectively. Older recipients with dementia had a 1.52-fold (95% confidence interval, 1.39 to 1.68) increased risk of graft loss and a 2.38-fold (95% confidence interval, 2.26 to 2.49) increased risk of mortality. We observed similar results for AD. We conclude that older KT recipients have a high risk of post-KT dementia and AD, and these sequelae associate with a profound effect on patient and graft survival.
引用
- McAdams-DeMarco MA, Bae S, Chu N, et al. Dementia and Alzheimer's Disease among Older Kidney Transplant Recipients. J Am Soc Nephrol. 2016. PMID: 27979990. doi:10.1681/ASN.2016080816
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。